106 related articles for article (PubMed ID: 10197966)
1. Binding preferences of hydroxamate inhibitors of the matrix metalloproteinase human fibroblast collagenase.
Toba S; Damodaran KV; Merz KM
J Med Chem; 1999 Apr; 42(7):1225-34. PubMed ID: 10197966
[TBL] [Abstract][Full Text] [Related]
2. Binding affinity of hydroxamate inhibitors of matrix metalloproteinase-2.
Zhang W; Hou TJ; Qiao XB; Huai S; Xu XJ
J Mol Model; 2004 Apr; 10(2):112-20. PubMed ID: 14986176
[TBL] [Abstract][Full Text] [Related]
3. High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor.
Moy FJ; Chanda PK; Chen JM; Cosmi S; Edris W; Levin JI; Powers R
J Mol Biol; 2000 Sep; 302(3):671-89. PubMed ID: 10986126
[TBL] [Abstract][Full Text] [Related]
4. Quantitative structure-activity relationship of human neutrophil collagenase (MMP-8) inhibitors using comparative molecular field analysis and X-ray structure analysis.
Matter H; Schwab W; Barbier D; Billen G; Haase B; Neises B; Schudok M; Thorwart W; Schreuder H; Brachvogel V; Lönze P; Weithmann KU
J Med Chem; 1999 Jun; 42(11):1908-20. PubMed ID: 10354399
[TBL] [Abstract][Full Text] [Related]
5. NMR solution structure of the catalytic fragment of human fibroblast collagenase complexed with a sulfonamide derivative of a hydroxamic acid compound.
Moy FJ; Chanda PK; Chen JM; Cosmi S; Edris W; Skotnicki JS; Wilhelm J; Powers R
Biochemistry; 1999 Jun; 38(22):7085-96. PubMed ID: 10353819
[TBL] [Abstract][Full Text] [Related]
6. High-resolution solution structure of the inhibitor-free catalytic fragment of human fibroblast collagenase determined by multidimensional NMR.
Moy FJ; Chanda PK; Cosmi S; Pisano MR; Urbano C; Wilhelm J; Powers R
Biochemistry; 1998 Feb; 37(6):1495-504. PubMed ID: 9484219
[TBL] [Abstract][Full Text] [Related]
7. Molecular docking studies of a group of hydroxamate inhibitors with gelatinase-A by molecular dynamics.
Hou T; Zhang W; Xu X
J Comput Aided Mol Des; 2002 Jan; 16(1):27-41. PubMed ID: 12197664
[TBL] [Abstract][Full Text] [Related]
8. Bis-substituted malonic acid hydroxamate derivatives as inhibitors of human neutrophil collagenase (MMP8).
Graf von Roedern E; Brandstetter H; Engh RA; Bode W; Grams F; Moroder L
J Med Chem; 1998 Jul; 41(16):3041-7. PubMed ID: 9685244
[TBL] [Abstract][Full Text] [Related]
9. Hydroxamate-based peptide inhibitors of matrix metalloprotease 2.
Jani M; Tordai H; Trexler M; Bányai L; Patthy L
Biochimie; 2005; 87(3-4):385-92. PubMed ID: 15781326
[TBL] [Abstract][Full Text] [Related]
10. 3-Hydroxy-4-arylsulfonyltetrahydropyranyl-3-hydroxamic acids are novel inhibitors of MMP-13 and aggrecanase.
Noe MC; Snow SL; Wolf-Gouveia LA; Mitchell PG; Lopresti-Morrow L; Reeves LM; Yocum SA; Liras JL; Vaughn M
Bioorg Med Chem Lett; 2004 Sep; 14(18):4727-30. PubMed ID: 15324896
[TBL] [Abstract][Full Text] [Related]
11. Molecular dynamics simulations of matrix metalloproteinase 2: role of the structural metal ions.
Díaz N; Suarez D
Biochemistry; 2007 Aug; 46(31):8943-52. PubMed ID: 17616173
[TBL] [Abstract][Full Text] [Related]
12. Binding of 5-phospho-D-arabinonohydroxamate and 5-phospho-D-arabinonate inhibitors to zinc phosphomannose isomerase from Candida albicans studied by polarizable molecular mechanics and quantum mechanics.
Roux C; Gresh N; Perera LE; Piquemal JP; Salmon L
J Comput Chem; 2007 Apr; 28(5):938-57. PubMed ID: 17253648
[TBL] [Abstract][Full Text] [Related]
13. Structure of recombinant mouse collagenase-3 (MMP-13).
Botos I; Meyer E; Swanson SM; Lemaître V; Eeckhout Y; Meyer EF
J Mol Biol; 1999 Oct; 292(4):837-44. PubMed ID: 10525409
[TBL] [Abstract][Full Text] [Related]
14. New beginnings for matrix metalloproteinase inhibitors: identification of high-affinity zinc-binding groups.
Puerta DT; Lewis JA; Cohen SM
J Am Chem Soc; 2004 Jul; 126(27):8388-9. PubMed ID: 15237990
[TBL] [Abstract][Full Text] [Related]
15. Sultam hydroxamates as novel matrix metalloproteinase inhibitors.
Cherney RJ; Mo R; Meyer DT; Hardman KD; Liu RQ; Covington MB; Qian M; Wasserman ZR; Christ DD; Trzaskos JM; Newton RC; Decicco CP
J Med Chem; 2004 Jun; 47(12):2981-3. PubMed ID: 15163180
[TBL] [Abstract][Full Text] [Related]
16. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
Hou T; Zhu L; Chen L; Xu X
J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
[TBL] [Abstract][Full Text] [Related]
17. Peptide hydrolysis catalyzed by matrix metalloproteinase 2: a computational study.
Díaz N; Suárez D
J Phys Chem B; 2008 Jul; 112(28):8412-24. PubMed ID: 18570467
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for the highly selective inhibition of MMP-13.
Engel CK; Pirard B; Schimanski S; Kirsch R; Habermann J; Klingler O; Schlotte V; Weithmann KU; Wendt KU
Chem Biol; 2005 Feb; 12(2):181-9. PubMed ID: 15734645
[TBL] [Abstract][Full Text] [Related]
19. Molecular dynamics study of zinc binding to cysteines in a peptide mimic of the alcohol dehydrogenase structural zinc site.
Brandt EG; Hellgren M; Brinck T; Bergman T; Edholm O
Phys Chem Chem Phys; 2009 Feb; 11(6):975-83. PubMed ID: 19177216
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of the stromelysin catalytic domain at 2.0 A resolution: inhibitor-induced conformational changes.
Chen L; Rydel TJ; Gu F; Dunaway CM; Pikul S; Dunham KM; Barnett BL
J Mol Biol; 1999 Oct; 293(3):545-57. PubMed ID: 10543949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
